Prdx3-flox Mouse
Common Name
Prdx3-flox
제품 ID
S-CKO-01214
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-11757-Prdx3-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Prdx3-flox Mouse (카탈로그 번호 S-CKO-01214)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Prdx3-flox
품종 계통계통 ID
CKOCMP-11757-Prdx3-B6J-VA
유전자명
제품 ID
S-CKO-01214
유전자 별칭
Aop1, Ef2l, Mer5, Prx3, SP22, TDXM, D0Tohi1
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 19
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000025961
NCBI 전사체 ID
NM_007452
타겟 영역
Exon 2
유효 영역 크기
~1.3 kb
유전자 연구 개요
Prdx3, peroxiredoxin 3, is a master regulator of mitochondrial oxidative stress. It functions as an efficient hydrogen peroxide (H₂O₂) scavenger, protecting cells from mitochondrial oxidative damage and apoptosis. It is involved in multiple biological pathways, such as those related to oxidative stress response, ferroptosis, and cell survival [1,2].
In animal models, Prdx3 has been shown to play significant roles in various diseases. In liver fibrosis, its expression is negatively correlated with the condition. PRDX3 knockdown in mice exacerbated hepatic fibrogenesis and hepatic stellate cell (HSC) activation, while HSC-specific PRDX3 overexpression attenuated liver fibrosis, with the mechanism involving the mitochondrial reactive oxygen species (ROS)/TGF-β1/Smad2/3 pathway [1].
In intestinal ischemia/reperfusion (I/R) injury, PRDX3 expression was decreased. Overexpression of PRDX3 in Caco-2 cells significantly attenuated hypoxia/reoxygenation (H/R)-induced mitochondrial oxidative damage and apoptosis. SIRT3-mediated deacetylation of PRDX3 was found to alleviate I/R-induced mitochondrial oxidative damage and apoptosis [2].
In pulmonary fibrosis, YAP1 promoted Prdx3 expression, and forced expression of Prdx3 inhibited senescence and improved mitochondrial dysfunction in bleomycin-treated MLE-12 cells, while Prdx3 depletion abrogated the protective effect of YAP1 [3].
In gastric cancer, PRDX3 was overexpressed in cancer tissue compared to adjacent non-cancer tissue. Silencing PRDX3 reduced the half-inhibitory concentration (IC50) of cisplatin in AGS and MKN-74 cell lines, increased apoptosis, and upregulated the expression of cleaved caspase-3 and Bax, indicating that PRDX3 increases cisplatin resistance in gastric cancer cells [4].
In uveal melanoma, high immunohistochemical expression of PRDX3 in primary tissue was associated with metastasis and poor survival [5]. In gastric cancer, the FOXM1-ASF1B-PRDX3 axis was identified, and ASF1B regulated PRDX3 transcription in a FOXM1-dependent manner, with PRDX3 playing a role in cell proliferation and oxidative stress balance [6].
In conclusion, Prdx3 is crucial for maintaining mitochondrial function and cell survival by scavenging H₂O₂. Studies using gene-knockout or conditional-knockout mouse models have revealed its significance in diseases like liver fibrosis, intestinal I/R injury, pulmonary fibrosis, gastric cancer, and uveal melanoma. These findings provide potential therapeutic targets for treating these diseases by targeting Prdx3 and its related pathways.
References:
1. Sun, Ruimin, Tian, Xinyao, Li, Yang, Zheng, Shusen, Yao, Jihong. 2022. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. In Redox biology, 54, 102378. doi:10.1016/j.redox.2022.102378. https://pubmed.ncbi.nlm.nih.gov/35779442/
2. Wang, Zhanyu, Sun, Ruimin, Wang, Guangzhi, Yao, Jihong, Tian, Xiaofeng. 2019. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury. In Redox biology, 28, 101343. doi:10.1016/j.redox.2019.101343. https://pubmed.ncbi.nlm.nih.gov/31655428/
3. Su, Wei, Guo, Yingying, Wang, Qianqian, Shan, Hongli, Liang, Haihai. 2024. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. In Experimental & molecular medicine, 56, 1643-1654. doi:10.1038/s12276-024-01277-0. https://pubmed.ncbi.nlm.nih.gov/38945958/
4. Yan, Hao, Cai, Xinyu, Fu, Shanshan, Zhang, Xiubin, Zhang, Jianna. . PRDX3 promotes resistance to cisplatin in gastric cancer cells. In Journal of cancer research and therapeutics, 18, 1994-2000. doi:10.4103/jcrt.jcrt_970_22. https://pubmed.ncbi.nlm.nih.gov/36647961/
5. Ramasamy, Pathma, Larkin, Anne-Marie, Linge, Annett, Kennedy, Susan, Meleady, Paula. 2019. PRDX3 is associated with metastasis and poor survival in uveal melanoma. In Journal of clinical pathology, 73, 408-412. doi:10.1136/jclinpath-2019-206173. https://pubmed.ncbi.nlm.nih.gov/31771972/
6. Zhao, Zhou, Cai, Zhaolun, Zhang, Su, Han, Junhong, Zhang, Bo. 2024. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. In Cancer letters, 589, 216796. doi:10.1016/j.canlet.2024.216796. https://pubmed.ncbi.nlm.nih.gov/38537775/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
